Background: Cell-based influenza vaccines can solve the problem of the frequent occurrence of egg adaptation-associated antigenic changes observed in egg-based vaccines. Seed viruses for cell-based vaccines can be prepared from clinical specimens by cell culture; however, clinical samples risk harboring respiratory viruses other than influenza virus. Therefore, it is necessary to investigate the patterns of co-infection in clinical samples and explore whether cell culture technology can selectively propa-
| INTRODUC TI ON
Influenza virus is highly transmissible and causes mild to severe illness, including high fever, headache, myalgia, and pneumonia.
Annual influenza epidemics worldwide cause approximately three to five million cases of severe illness and 290 000-650 000 deaths every year, resulting in a great social impact. 1 The economic burden of influenza has been estimated to be $47.2-$149.5 billion per year in the United States. 2, 3 Influenza vaccine, one of the most effective measures to prevent influenza virus infection, is mainly produced in embryonated chicken eggs. However, influenza viruses propagated in eggs frequently acquire antigenic alteration through host adaptation, [4] [5] [6] [7] [8] [9] The MDCK cell line was established from the kidney of a healthy cocker spaniel dog in 1958 and has a long history in the studies of influenza viruses. The conventional MDCK cell with adherent growth (MDCK-A) is a good candidate for the preparation of vaccine seed viruses, since it supports efficient growth of human influenza viruses. 10, 11 The MDCK33016PF suspension cell line, designated as MDCK-S in this paper, was first developed and utilized to produce seasonal influenza vaccines. [11] [12] [13] Suspension cells are superior to adherent cells owing to the following advantages: simpler culture process without micro-carrier beads, lower cost, and higher virus yield. Therefore, MDCK-S could be a suitable substrate for influenza vaccine seed preparation.
LLC-MK2, established from the kidney of a healthy rhesus monkey, has also been used to propagate a variety of viruses, including the influenza virus. [14] [15] [16] LLC-MK2D, which is a sub-line of LLC-MK2, was proven to be non-tumorigenic in nude mice and free of specific adventitious agents. This cell line could be a promising candidate for the preparation of vaccine seed viruses, since its safety is confirmed and it can be used in practical applications with little delay.
In this study, we analyzed the pattern of co-infection of respiratory viruses in clinical specimens and evaluated the ability of MDCK-S, MDCK-A, and LLC-MK2D cells to propagate influenza viruses while eliminating other respiratory viruses. 
| MATERIAL S AND ME THODS

| Clinical specimens
| Cell culture and virus passaging
MDCK-S cells were cultured in 500-mL disposable spinner flasks (Corning, Corning, NY, USA) with 100 mL of chemically defined medium (CDM) at 37°C, 5% CO 2 , and 100 rpm on a shaking platform (MIR-S100C; Sanyo, Osaka, Japan). MDCK-A and LLC-MK2D cells were subcultured in MEM supplemented with 10% fetal bovine serum (FBS) in a 75-cm 2 culture flask at 37°C under 5% CO 2 .
All adventitious virus-positive specimens were inoculated into the cultures of these cells. For virus isolation using MDCK-S, the infection medium was prepared with 37.5 µg/mL of neomycin (Gibco, Carlsbad, CA, USA) to prevent bacterial contamination from specimens and 1 µg/mL of TrypZean (Sigma-Aldrich, St.
Louis, MO, USA) to support viral growth. The density of MDCK-S in the infection medium was adjusted to 1 × 10 6 cells/mL, and 5 mL of cell suspension was distributed to 50-mL filter-capped tubes. To examine if there were specific patterns of correlation between the detected viruses, all virus pairs in Table 1 were evaluated with however, the differences in detection rates between influenza virus and others were not significant. In the double infection 2 group, an isolate of CVEV was obtained from four specimens (25%), although no influenza virus was amplified during cell passages.
| ResPlex II assay
To examine further whether MDCK-S, MDCK-A, and LLC-MK2D can eliminate contaminating viruses, we passaged clinical specimens containing respiratory viruses other than influenza virus in the three cell lines. The ResPlex II assay did not detect any respiratory virus in the cell-passaged samples from all cell lines (Table 4) . CVEV, RHV, RSVA, RSVB, OC43, and NL63 were 
TA B L E 1 Distribution of detected viruses
Detected virus
Number of virus-positive samples
Rate of viruspositive samples (%)
| D ISCUSS I ON
In this study, using the ResPlex II assay, we analyzed the specific pat- (1/1) 0% (0/1) 0% (0/1) 0% (0/1) *The detection rate of influenza virus was significantly higher than that of the other co-infected viruses (P < .01). **The detection rate of influenza virus was significantly higher than that of the other co-infected viruses (P < .05).
with other viruses in clinical specimens should not be ignored, and it would thus be necessary to select cell substrates that can eliminate the contaminating viruses and amplify influenza viruses.
Roth et al reported that MDCK 33016PF cells (identical to
MDCK-S cells) could remove adventitious viruses and propagate influenza viruses. 13 In the present study, we analyzed the property of MDCK-A and LLC-MK2D as well as that of MDCK-S.
The two MDCK cell lines showed different growth phenotypes; In this situation, reverse genetics is useful because plasmids with no virus are starting materials to produce influenza viruses.
MDCK-S is a suspension cell line, whereas MDCK-
A(H3N2) viruses particularly have serious problems such as low replication efficiency in embryonated hen eggs and critical antigenic alterations during egg adaptation. 19, 20 Recently, the US-FDA approved an influenza vaccine with cell-derived seed virus. 21 It is thus expected that a completely cell-based A(H3N2) vaccine will pave the way to overcome the difficulties associated with egg-based vaccines. 
MDCK-S and MDCK-
